nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—TP53—chronic obstructive pulmonary disease	0.0213	0.852	CrCbGaD
Nitazoxanide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00518	0.00531	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00514	0.00527	CcSEcCtD
Nitazoxanide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00497	0.0051	CcSEcCtD
Nitazoxanide—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00495	0.00508	CcSEcCtD
Nitazoxanide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00481	0.00493	CcSEcCtD
Nitazoxanide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00468	0.0048	CcSEcCtD
Nitazoxanide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00463	0.00475	CcSEcCtD
Nitazoxanide—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00462	0.00474	CcSEcCtD
Nitazoxanide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00451	0.00462	CcSEcCtD
Nitazoxanide—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.0045	0.00462	CcSEcCtD
Nitazoxanide—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.0045	0.00462	CcSEcCtD
Nitazoxanide—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00446	0.00457	CcSEcCtD
Nitazoxanide—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00446	0.00457	CcSEcCtD
Nitazoxanide—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00445	0.00457	CcSEcCtD
Nitazoxanide—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00441	0.00452	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00438	0.00449	CcSEcCtD
Nitazoxanide—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00436	0.00448	CcSEcCtD
Nitazoxanide—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00434	0.00445	CcSEcCtD
Nitazoxanide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0043	0.00441	CcSEcCtD
Nitazoxanide—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00426	0.00437	CcSEcCtD
Nitazoxanide—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00425	0.00436	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00422	0.00433	CcSEcCtD
Nitazoxanide—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00421	0.00432	CcSEcCtD
Nitazoxanide—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00418	0.00429	CcSEcCtD
Nitazoxanide—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00416	0.00427	CcSEcCtD
Nitazoxanide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00416	0.00426	CcSEcCtD
Nitazoxanide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00412	0.00423	CcSEcCtD
Nitazoxanide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00412	0.00423	CcSEcCtD
Nitazoxanide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00409	0.0042	CcSEcCtD
Nitazoxanide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00403	0.00414	CcSEcCtD
Nitazoxanide—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.004	0.00411	CcSEcCtD
Nitazoxanide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.004	0.0041	CcSEcCtD
Nitazoxanide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00399	0.0041	CcSEcCtD
Nitazoxanide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00396	0.00406	CcSEcCtD
Nitazoxanide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00396	0.00406	CcSEcCtD
Nitazoxanide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.00405	CcSEcCtD
Nitazoxanide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00394	0.00404	CcSEcCtD
Nitazoxanide—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00393	0.00403	CcSEcCtD
Nitazoxanide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00389	0.00399	CcSEcCtD
Nitazoxanide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00386	0.00396	CcSEcCtD
Nitazoxanide—Chills—Salbutamol—chronic obstructive pulmonary disease	0.0038	0.0039	CcSEcCtD
Nitazoxanide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00379	0.00389	CcSEcCtD
Nitazoxanide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00378	0.00388	CcSEcCtD
Nitazoxanide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00378	0.00388	CcSEcCtD
Nitazoxanide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00376	0.00385	CcSEcCtD
Nitazoxanide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00376	0.00385	CcSEcCtD
Nitazoxanide—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00374	0.00384	CcSEcCtD
Nitazoxanide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.00374	0.00384	CcSEcCtD
Nitazoxanide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00373	0.00383	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—ALB—chronic obstructive pulmonary disease	0.00371	0.148	CrCbGaD
Nitazoxanide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00369	0.00378	CcSEcCtD
Nitazoxanide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00368	0.00377	CcSEcCtD
Nitazoxanide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00366	0.00376	CcSEcCtD
Nitazoxanide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00366	0.00376	CcSEcCtD
Nitazoxanide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00364	0.00374	CcSEcCtD
Nitazoxanide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00364	0.00373	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00363	0.00372	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00363	0.00372	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.0036	0.00369	CcSEcCtD
Nitazoxanide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00359	0.00368	CcSEcCtD
Nitazoxanide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00357	0.00367	CcSEcCtD
Nitazoxanide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00357	0.00366	CcSEcCtD
Nitazoxanide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00355	0.00364	CcSEcCtD
Nitazoxanide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00352	0.00361	CcSEcCtD
Nitazoxanide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00352	0.00361	CcSEcCtD
Nitazoxanide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00348	0.00357	CcSEcCtD
Nitazoxanide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00346	0.00355	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00343	0.00351	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00342	0.00351	CcSEcCtD
Nitazoxanide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00338	0.00347	CcSEcCtD
Nitazoxanide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00337	0.00346	CcSEcCtD
Nitazoxanide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00337	0.00346	CcSEcCtD
Nitazoxanide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.00341	CcSEcCtD
Nitazoxanide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00333	0.00341	CcSEcCtD
Nitazoxanide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00333	0.00341	CcSEcCtD
Nitazoxanide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00331	0.0034	CcSEcCtD
Nitazoxanide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00331	0.0034	CcSEcCtD
Nitazoxanide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00331	0.00339	CcSEcCtD
Nitazoxanide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00329	0.00337	CcSEcCtD
Nitazoxanide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00329	0.00337	CcSEcCtD
Nitazoxanide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00326	0.00334	CcSEcCtD
Nitazoxanide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00325	0.00334	CcSEcCtD
Nitazoxanide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00325	0.00334	CcSEcCtD
Nitazoxanide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00324	0.00333	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00323	0.00331	CcSEcCtD
Nitazoxanide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00327	CcSEcCtD
Nitazoxanide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00327	CcSEcCtD
Nitazoxanide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00327	CcSEcCtD
Nitazoxanide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00317	0.00325	CcSEcCtD
Nitazoxanide—Infection—Formoterol—chronic obstructive pulmonary disease	0.00317	0.00325	CcSEcCtD
Nitazoxanide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00314	0.00322	CcSEcCtD
Nitazoxanide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00312	0.0032	CcSEcCtD
Nitazoxanide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00312	0.0032	CcSEcCtD
Nitazoxanide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00311	0.00319	CcSEcCtD
Nitazoxanide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00311	0.00319	CcSEcCtD
Nitazoxanide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0031	0.00318	CcSEcCtD
Nitazoxanide—Infection—Montelukast—chronic obstructive pulmonary disease	0.0031	0.00318	CcSEcCtD
Nitazoxanide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00309	0.00317	CcSEcCtD
Nitazoxanide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.00315	CcSEcCtD
Nitazoxanide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00309	CcSEcCtD
Nitazoxanide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00299	0.00307	CcSEcCtD
Nitazoxanide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00297	0.00304	CcSEcCtD
Nitazoxanide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00296	0.00304	CcSEcCtD
Nitazoxanide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00294	0.00301	CcSEcCtD
Nitazoxanide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00299	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00291	0.00298	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00291	0.00298	CcSEcCtD
Nitazoxanide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00288	0.00296	CcSEcCtD
Nitazoxanide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00288	0.00296	CcSEcCtD
Nitazoxanide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00287	0.00294	CcSEcCtD
Nitazoxanide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00287	0.00294	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00285	0.00292	CcSEcCtD
Nitazoxanide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00291	CcSEcCtD
Nitazoxanide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00291	CcSEcCtD
Nitazoxanide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00283	0.0029	CcSEcCtD
Nitazoxanide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00281	0.00288	CcSEcCtD
Nitazoxanide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00281	0.00288	CcSEcCtD
Nitazoxanide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0028	0.00287	CcSEcCtD
Nitazoxanide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00278	0.00285	CcSEcCtD
Nitazoxanide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00277	0.00284	CcSEcCtD
Nitazoxanide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00275	0.00282	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00281	CcSEcCtD
Nitazoxanide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00273	0.0028	CcSEcCtD
Nitazoxanide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.0028	CcSEcCtD
Nitazoxanide—Pain—Formoterol—chronic obstructive pulmonary disease	0.00273	0.0028	CcSEcCtD
Nitazoxanide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.0028	CcSEcCtD
Nitazoxanide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00272	0.00279	CcSEcCtD
Nitazoxanide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00272	0.00279	CcSEcCtD
Nitazoxanide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00275	CcSEcCtD
Nitazoxanide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00274	CcSEcCtD
Nitazoxanide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00266	0.00273	CcSEcCtD
Nitazoxanide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00265	0.00272	CcSEcCtD
Nitazoxanide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00264	0.00271	CcSEcCtD
Nitazoxanide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00264	0.00271	CcSEcCtD
Nitazoxanide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.0027	CcSEcCtD
Nitazoxanide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00263	0.0027	CcSEcCtD
Nitazoxanide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00263	0.00269	CcSEcCtD
Nitazoxanide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00269	CcSEcCtD
Nitazoxanide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00261	0.00268	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.00268	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00261	0.00268	CcSEcCtD
Nitazoxanide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00264	CcSEcCtD
Nitazoxanide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00264	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00255	0.00262	CcSEcCtD
Nitazoxanide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00259	CcSEcCtD
Nitazoxanide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00259	CcSEcCtD
Nitazoxanide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00259	CcSEcCtD
Nitazoxanide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00259	CcSEcCtD
Nitazoxanide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00251	0.00258	CcSEcCtD
Nitazoxanide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00249	0.00256	CcSEcCtD
Nitazoxanide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00249	0.00255	CcSEcCtD
Nitazoxanide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00249	0.00255	CcSEcCtD
Nitazoxanide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00248	0.00255	CcSEcCtD
Nitazoxanide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00248	0.00254	CcSEcCtD
Nitazoxanide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00247	0.00253	CcSEcCtD
Nitazoxanide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00247	0.00253	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00253	CcSEcCtD
Nitazoxanide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00244	CcSEcCtD
Nitazoxanide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00244	CcSEcCtD
Nitazoxanide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00241	CcSEcCtD
Nitazoxanide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00241	CcSEcCtD
Nitazoxanide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00241	CcSEcCtD
Nitazoxanide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.0023	0.00236	CcSEcCtD
Nitazoxanide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00235	CcSEcCtD
Nitazoxanide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00235	CcSEcCtD
Nitazoxanide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00226	0.00231	CcSEcCtD
Nitazoxanide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00226	0.00231	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00225	0.00231	CcSEcCtD
Nitazoxanide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00224	0.0023	CcSEcCtD
Nitazoxanide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00228	CcSEcCtD
Nitazoxanide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00221	0.00227	CcSEcCtD
Nitazoxanide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00224	CcSEcCtD
Nitazoxanide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00224	CcSEcCtD
Nitazoxanide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00222	CcSEcCtD
Nitazoxanide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00219	CcSEcCtD
Nitazoxanide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00213	0.00219	CcSEcCtD
Nitazoxanide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00216	CcSEcCtD
Nitazoxanide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00216	CcSEcCtD
Nitazoxanide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00212	CcSEcCtD
Nitazoxanide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00211	CcSEcCtD
Nitazoxanide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00208	CcSEcCtD
Nitazoxanide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00208	CcSEcCtD
Nitazoxanide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Nitazoxanide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Nitazoxanide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Nitazoxanide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00201	0.00206	CcSEcCtD
Nitazoxanide—Headache—Formoterol—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Nitazoxanide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00205	CcSEcCtD
Nitazoxanide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00204	CcSEcCtD
Nitazoxanide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00199	0.00204	CcSEcCtD
Nitazoxanide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00202	CcSEcCtD
Nitazoxanide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00202	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00196	0.00201	CcSEcCtD
Nitazoxanide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00201	CcSEcCtD
Nitazoxanide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00196	CcSEcCtD
Nitazoxanide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00191	0.00196	CcSEcCtD
Nitazoxanide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Nitazoxanide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Nitazoxanide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00195	CcSEcCtD
Nitazoxanide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Nitazoxanide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Nitazoxanide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00194	CcSEcCtD
Nitazoxanide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00186	0.00191	CcSEcCtD
Nitazoxanide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00186	0.0019	CcSEcCtD
Nitazoxanide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00187	CcSEcCtD
Nitazoxanide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00183	CcSEcCtD
Nitazoxanide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00178	0.00183	CcSEcCtD
Nitazoxanide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00173	0.00177	CcSEcCtD
Nitazoxanide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.00174	CcSEcCtD
Nitazoxanide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00173	CcSEcCtD
Nitazoxanide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00156	0.0016	CcSEcCtD
Nitazoxanide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00152	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00146	CcSEcCtD
Nitazoxanide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00146	CcSEcCtD
Nitazoxanide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00142	CcSEcCtD
Nitazoxanide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00141	CcSEcCtD
Nitazoxanide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Nitazoxanide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00136	CcSEcCtD
Nitazoxanide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00134	CcSEcCtD
Nitazoxanide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00133	CcSEcCtD
Nitazoxanide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00131	CcSEcCtD
Nitazoxanide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00129	CcSEcCtD
Nitazoxanide—Infection—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00128	CcSEcCtD
Nitazoxanide—Shock—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00127	CcSEcCtD
Nitazoxanide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00126	CcSEcCtD
Nitazoxanide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00123	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00117	CcSEcCtD
Nitazoxanide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00117	CcSEcCtD
Nitazoxanide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00116	CcSEcCtD
Nitazoxanide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00113	CcSEcCtD
Nitazoxanide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Nitazoxanide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Nitazoxanide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00112	CcSEcCtD
Nitazoxanide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00111	CcSEcCtD
Nitazoxanide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00107	0.0011	CcSEcCtD
Nitazoxanide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00106	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00105	CcSEcCtD
Nitazoxanide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00105	CcSEcCtD
Nitazoxanide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000992	0.00102	CcSEcCtD
Nitazoxanide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000992	0.00102	CcSEcCtD
Nitazoxanide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000925	0.000949	CcSEcCtD
Nitazoxanide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000901	0.000924	CcSEcCtD
Nitazoxanide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000888	0.000911	CcSEcCtD
Nitazoxanide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000859	0.000881	CcSEcCtD
Nitazoxanide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00083	0.000851	CcSEcCtD
Nitazoxanide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000798	0.000819	CcSEcCtD
Nitazoxanide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000791	0.000812	CcSEcCtD
Nitazoxanide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000791	0.000811	CcSEcCtD
Nitazoxanide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000786	0.000807	CcSEcCtD
Nitazoxanide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000746	0.000765	CcSEcCtD
